IDXX · IDEXX Laboratories, Inc.
Healthcare NMS United States idexx.com ↗
BEARISH BUY
Val Gro Qua Mom Sta Cap P/S10.11 P/E Fwd P/E34.50 PEG3.56 52W –  RSI Target$707.0 (+24.1%) Beta1.55 Div
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Diagnostics & Research Westbrook, United States 11,000 employees
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 55 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
0Bullish
1Bearish
0Neutral
▼ Double Top — Two peaks ~$589.82 — bearish reversal confirmed

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 04, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +24.1%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
9
5
1
BuyHoldSell
Price Target Range
$707.0 +24.1% upside
Low $470 High $805
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
UBS Neutral ↔ Maintain 2026-07-27
Citigroup Neutral ● Initiate 2026-04-15
Stifel Buy ↔ Maintain 2026-03-31
Piper Sandler Neutral ↔ Maintain 2026-02-09
Barclays Overweight ↔ Maintain 2026-02-05
BTIG Buy ↔ Maintain 2026-02-03
Morgan Stanley Overweight ↔ Maintain 2025-11-04
JP Morgan Overweight ↔ Maintain 2025-11-04
UBS 2026-07-27
Neutral ↔ Maintain
Citigroup 2026-04-15
Neutral ● Initiate
Stifel 2026-03-31
Buy ↔ Maintain
Piper Sandler 2026-02-09
Neutral ↔ Maintain
Barclays 2026-02-05
Overweight ↔ Maintain
BTIG 2026-02-03
Buy ↔ Maintain
Morgan Stanley 2025-11-04
Overweight ↔ Maintain
JP Morgan 2025-11-04
Overweight ↔ Maintain
Profitability
Gross Margin 62.05%TTM
Op. Margin 31.78%TTM
ROE 72.91%TTM
Rev. Growth 14.30%YoY
Free Cash Flow 786.84MTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 71.04MRQ
Current Ratio 1.12MRQ
Cash 200.53MMRQ
Total Debt 1.11BMRQ
Net Debt MRQ
How IDXX Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap44.95B
Enterprise Value45.85B
Trailing P/E41.86
Forward P/E34.50
PEG Ratio (5yr)3.56
Price/Sales (ttm)10.11
Price/Book (mrq)29.01
EV/Revenue10.31
EV/EBITDA29.66
Share Statistics
Avg Vol (3m)651.38K
Shares Outstanding78.88M
Float78.58M
% Held by Insiders0.22%
% Held by Institutions96.16%
Short Ratio2.84
Short % of Float3.04%
Profitability
Gross Margin62.05%
Operating Margin (ttm)31.78%
Profit Margin24.63%
Return on Assets (ttm)26.46%
Return on Equity (ttm)72.91%
Income Statement
Revenue (ttm)4.45B
Revenue Growth (yoy)14.30%
Gross Profit (ttm)2.76B
EBITDA1.55B
Net Income (ttm)1.10B
Diluted EPS (ttm)13.61
EPS Growth (yoy)17.20%
Balance Sheet
Total Cash (mrq)200.53M
Total Debt (mrq)1.11B
Debt / Equity (mrq)71.04
Current Ratio (mrq)1.12
Book Value / Share19.64
Operating CF (ttm)1.21B
Free Cash Flow (ttm)786.84M
Trading & Dividends
Beta (5Y)1.55
50-Day MA555.77
200-Day MA621.46
Fwd Dividend YieldN/A
Payout Ratio0.00%
Ownership Breakdown
Institutional 96.16% Insider 0.22% Public 3.6%
Short Interest 3.04% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in IDXX in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-06-01 FENNELL GEORGE Officer 639
2026-05-07 SZOSTAK MARGARET ANNE Director 257
2026-05-07 JUNIUS DANIEL M Director 257
2026-05-07 PEACOCK KAREN Director 101
2026-05-07 KINGSLEY LAWRENCE D Director 339
2026-05-07 HOOLEY JOSEPH L. Director 158
2026-05-07 VANDEBROEK SOPHIE V Director 257
2026-04-30 HOOLEY JOSEPH L. Director Stock Award(Grant) at price 560.80 per share. 43 $24,114
2026-03-03 UNDERBERG SHARON E General Counsel Conversion of Exercise of derivative security at price 505.53 per share. 197 $99,589
2026-03-03 HUNT NIMRATA K Officer Sale at price 634.57 per share. 1,758 $1,115,577
2026-02-27 MAZELSKY JONATHAN JAY Chief Executive Officer Conversion of Exercise of derivative security at price 141.60 - 505.53 per share. 23,523 $3,402,551
2026-02-26 MAZELSKY JONATHAN JAY Chief Executive Officer Sale at price 650.67 - 663.04 per share. 23,326 $15,338,081
2026-02-26 HUNT NIMRATA K Officer Sale at price 661.54 per share. 2,693 $1,781,531
2026-02-19 ERICKSON MICHAEL G Officer Conversion of Exercise of derivative security at price 141.60 - 544.08 per share. 7,770 $1,460,329
2026-02-17 VANDEBROEK SOPHIE V Director Conversion of Exercise of derivative security at price 333.90 per share. 945 $315,536
2026-02-17 VANDEBROEK SOPHIE V Director Sale at price 628.56 - 628.65 per share. 1,464 $920,293
2026-02-17 ERICKSON MICHAEL G Officer Sale at price 623.76 - 629.86 per share. 5,371 $3,369,666
2026-02-13 SMITH MARTIN ALEXANDER Officer 1,004
2026-02-13 UNDERBERG SHARON E General Counsel 832
2026-02-13 LANE MICHAEL J Officer 1,092
2026-02-13 HUNT NIMRATA K Officer 2,587
2026-02-13 JOHNSON MICHAEL PERKINS Officer 573
2026-02-13 SCHRECK MICHAEL Officer 1,959
2026-02-13 ERICKSON MICHAEL G Officer 2,363
2026-02-13 EMERSON ANDREW Chief Financial Officer 456
FENNELL GEORGE Officer
2026-06-01 639 sh
SZOSTAK MARGARET ANNE Director
2026-05-07 257 sh
JUNIUS DANIEL M Director
2026-05-07 257 sh
PEACOCK KAREN Director
2026-05-07 101 sh
KINGSLEY LAWRENCE D Director
2026-05-07 339 sh
HOOLEY JOSEPH L. Director
2026-05-07 158 sh
VANDEBROEK SOPHIE V Director
2026-05-07 257 sh
HOOLEY JOSEPH L. Director
Stock Award(Grant) at price 560.80 per share.
2026-04-30 43 sh $24,114
UNDERBERG SHARON E General Counsel
Conversion of Exercise of derivative security at price 505.53 per share.
2026-03-03 197 sh $99,589
HUNT NIMRATA K Officer
Sale at price 634.57 per share.
2026-03-03 1,758 sh $1,115,577
MAZELSKY JONATHAN JAY Chief Executive Officer
Conversion of Exercise of derivative security at price 141.60 - 505.53 per share.
2026-02-27 23,523 sh $3,402,551
MAZELSKY JONATHAN JAY Chief Executive Officer
Sale at price 650.67 - 663.04 per share.
2026-02-26 23,326 sh $15,338,081
HUNT NIMRATA K Officer
Sale at price 661.54 per share.
2026-02-26 2,693 sh $1,781,531
ERICKSON MICHAEL G Officer
Conversion of Exercise of derivative security at price 141.60 - 544.08 per share.
2026-02-19 7,770 sh $1,460,329
VANDEBROEK SOPHIE V Director
Conversion of Exercise of derivative security at price 333.90 per share.
2026-02-17 945 sh $315,536
VANDEBROEK SOPHIE V Director
Sale at price 628.56 - 628.65 per share.
2026-02-17 1,464 sh $920,293
ERICKSON MICHAEL G Officer
Sale at price 623.76 - 629.86 per share.
2026-02-17 5,371 sh $3,369,666
SMITH MARTIN ALEXANDER Officer
2026-02-13 1,004 sh
UNDERBERG SHARON E General Counsel
2026-02-13 832 sh
LANE MICHAEL J Officer
2026-02-13 1,092 sh
HUNT NIMRATA K Officer
2026-02-13 2,587 sh
JOHNSON MICHAEL PERKINS Officer
2026-02-13 573 sh
SCHRECK MICHAEL Officer
2026-02-13 1,959 sh
ERICKSON MICHAEL G Officer
2026-02-13 2,363 sh
EMERSON ANDREW Chief Financial Officer
2026-02-13 456 sh